At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
Remifentanil +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IV Study to Investigate the Effects of Varied Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes
In Brief
A Phase 4 clinical trial evaluating Remifentanil, Propofol, and 1 other intervention for Induction of Anaesthesia. Completed, enrolled 100 participants across 1 site.
Detailed Summary
A prospective, randomised, phase IV trial including 150 patients. To evaluate the effects of varied concentrations of remifentanil on the proposal requirements for the loss of consciousness and response to pain and to evaluate the haemodynamic changes and processed EEG (BIS) during induction of anaesthesia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInduction of Anaesthesia
CountriesHong Kong
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 2014
Enrollment StartFeb 2015
Primary CompletionAug 2015
TodayJul 2026
First PostedNov 10, 2014
Enrollment StartFeb 1, 2015
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.6 years ago
Interventions
Remifentanildrug
short acting opiate
Propofoldrug
hypnotic drug
Bispectral indexother
electroencephalograph